Sign In
Buy TMDX
$76.51
+0.380 (+0.499%)
At Close: Jul 31, 2026
David Abrams Buys 3 Stocks in 1st Quarter
03:34pm, Friday, 21'st May 2021
David Abrams (Trades, Portfolio), the leader of Abrams Capital Management, disclosed his first-quarter portfolio earlier this month.
Transmedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q1 2021 Results - Earnings Call Transcript
03:12am, Wednesday, 05'th May 2021
Transmedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q1 2021 Results - Earnings Call Transcript
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates
07:32pm, Tuesday, 04'th May 2021
TransMedics (TMDX) delivered earnings and revenue surprises of -3.57% and 1.78%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: TransMedics Group Q1 Earnings
05:19pm, Tuesday, 04'th May 2021
Shares of TransMedics Group (NASDAQ:TMDX) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 30.95% over the past year to ($0.29), wh
TransMedics Reports First Quarter 2021 Financial Results
04:01pm, Tuesday, 04'th May 2021
ANDOVER, Mass., May 4, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-sta
1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into Riches
07:43am, Thursday, 22'nd Apr 2021
TransMedics is looking to disrupt an entire industry and help thousands of transplant patients in the U.S. in the process.
TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021
04:05pm, Tuesday, 20'th Apr 2021
ANDOVER, Mass., April 20, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics: Organ Transplant Preservation Technology With Upcoming Catalysts
10:24am, Friday, 16'th Apr 2021
TransMedics: Organ Transplant Preservation Technology With Upcoming Catalysts
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System
10:20pm, Tuesday, 06'th Apr 2021
ANDOVER, Mass., April 6, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
How Jonah Lupton Expects TransMedics Group Stock To React To FDA Decision
05:30pm, Tuesday, 06'th Apr 2021
Jonah Lupton of Lupton Capital was focused on TransMedics Group Inc (NASDAQ: TMDX) Tuesday. The Nasdaq halted trading in TransMedics stock while the FDA reviews the company's OCS Heart System.
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System
07:05am, Tuesday, 06'th Apr 2021
ANDOVER, Mass., April 6, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
Got $2,000? These 3 Unstoppable Stocks Could More Than Double Your Money
06:01am, Friday, 12'th Mar 2021
And it probably won't take them long to do it.
TransMedics Group's (TMDX) CEO Waleed Hassanein on Q4 2020 Results - Earnings Call Transcript
09:56pm, Tuesday, 02'nd Mar 2021
TransMedics Group's (TMDX) CEO Waleed Hassanein on Q4 2020 Results - Earnings Call Transcript
TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates
06:10pm, Tuesday, 02'nd Mar 2021
TransMedics (TMDX) delivered earnings and revenue surprises of 8.00% and 24.62%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
TransMedics Group: Q4 Earnings Insights
04:38pm, Tuesday, 02'nd Mar 2021
Shares of TransMedics Group (NASDAQ:TMDX) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 46.51% over the past year to ($0.23),
